News 2023-09-28
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia.
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia. PCS programs are designed to stimulate in-depth discussions on common and/or leading bottleneck issues related to crystallization of drug substance (DS) as well as the intermediates, the technologies and solutions that are available or underdevelopment. The discussions help new medicine developers to make educated and phase-appropriate decisions, and crystallization experts to understand better the critical needs for providing effective solutions.
The Pharma Crystallization Summit (PCS) has been serving effectively for bridging the gap between drug substance (DS) and drug product (DP) developments. PCS 2023 will be held on October 5 – 6 at New Jersey Institute of Technology (NJIT), Newark, NJ, USA. Extending from the valued topics in the past, this 4th PCS will focus on the following topics:
Session I: Enabling Greener DS Synthetics Routes
Session II: Enabling Desired DS Quality Attributes
Session III: Enabling Improved DP Performance
Panel Discussion Topics:
1) Crystallization challenges and dream solutions supporting synthetic route optimization
2) API isolation challenges and better solutions to ensure robust production
3) Addressing formulation challenges via particle engineering and co-processing
End of Summit & See you in 2024!
Others
More
News 2026-10-24
Porton Shared Complex Bioconjugate Development Strategies at the 17th World ADC San Diego
As a conference partner, Porton contributed a scientific presentation and poster addressing the technical challenges of developing ADCs and emerging bioconjugates.
News 2026-10-22
Simplifying Synthesis with Radical Cross-Coupling: Prof. Phil S. Baran of Scripps Research Lectures at Porton
The event was hosted by Dr. Yongli Zhong, CSO, and attended by Mr. Oliver Ju, Chairman and CEO; Mr. Yunxing Yin, VP and Head of the Small Molecule Platform, and more than 200 R&D and technical staff.
